A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia
MH Kollef, J Chastre, M Clavel, MI Restrepo, B Michiels… - Critical Care, 2012 - Springer
Introduction The aim of this study was to compare a 7-day course of doripenem to a 10-day
course of imipenem-cilastatin for ventilator-associated pneumonia (VAP) due to Gram …
course of imipenem-cilastatin for ventilator-associated pneumonia (VAP) due to Gram …
Management and prevention of ventilator-associated pneumonia caused by multidrug-resistant pathogens
PE Grgurich, J Hudcova, Y Lei, A Sarwar… - Expert review of …, 2012 - Taylor & Francis
Ventilator-associated pneumonia (VAP) due to multidrug-resistant (MDR) pathogens is a
leading healthcare-associated infection in mechanically ventilated patients. The incidence of …
leading healthcare-associated infection in mechanically ventilated patients. The incidence of …
Multidrug-resistant organisms and antibiotic management
PS Barie - Surgical Clinics, 2012 - surgical.theclinics.com
Antibiotic resistance describes a set of conditions whereby a microorganism is able to
survive exposure to an antibiotic. Whereas a genetic mutation in bacteria, whether …
survive exposure to an antibiotic. Whereas a genetic mutation in bacteria, whether …
Year in review in Intensive Care Medicine 2011. II. Cardiovascular, infections, pneumonia and sepsis, critical care organization and outcome, education …
M Antonelli, M Bonten, J Chastre, G Citerio… - Intensive care …, 2012 - Springer
Mebazaa and colleagues in two interesting papers [1, 2] described the clinical presentation,
management, and outcomes of acute heart failure (AHF) through the Acute Heart Failure …
management, and outcomes of acute heart failure (AHF) through the Acute Heart Failure …